Cell Harvesting Market Size, Share, Growth, and Industry Analysis, By Type (Manual and Automated), By Application (Biopharmaceutical and Stem Cell Research), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

CELL HARVESTING MARKET OVERVIEW

The global cell harvesting market size was USD 0.2318 billion in 2025 and is projected to touch USD 0.3540 billion by 2034, exhibiting a CAGR of 4.82% during the forecast period.

The cell harvesting market is growing at a significant pace on account of the increasing growth of the bio-technology and regenerative medicine industries worldwide. Cell harvesting is a process of separation and collection of live cells for processing applications including stem cell therapy, cancer research, vaccine development, and biopharmaceutical production and is an important procedure in cell culture and bioprocessing. Growing demand for personalized medicine and increasing incidences of chronic, life-threatening and autoimmune diseases has propelled investments in novel cell therapies and clinical research. Automated cell harvesting products are emerging, as they enhance efficiency and minimize contamination risk, while allowing reproducibility in mass production. In addition, the increasing number of public and private funding for cell-based research and technological advancement in bioprocessing are also contributing to the market growth. The growing investments in biological pharmaceutical production in new economies is also driving the need of the cell harvesting technology that offers high throughput, efficient, and scalable.

Alongside this, there is a considerable transition to closed and automated harvesting systems that guarantee adherence to the robust regulatory standards for good manufacturing practices (GMP). The advancement of artificial intelligence (AI) and machine learning (ML) technology in cell processing is leading to improved real-time monitoring, yield enhancement and data reliability. Increasing demand for monoclonal antibodies, vaccines, and gene therapies has further consolidated the market outlook. Leading players are focusing on collaboration and R&D to create flexible, high throughput systems that can process multiple cell types. With the world of healthcare turning to regenerative medicine and biologics, the cell harvest market is expected to grow sustainably, propelled by innovation, automation, and clinical adoption.

COVID-19 IMPACT

Cell Harvesting Industry Had a Negative Effect Due to supply chain disruption during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The impact of the COVID-19 pandemic on the cell harvesting market was varied. At first, temporary disruptions in global supply chains and closures of research laboratories and biomanufacturing facilities presented barriers to equipment availability and temporary reductions in clinical trial activities. Limitations on international trade and access to manpower also contributed to the delay in new system installations and technology upgrades for the different research organizations. With the advancement of the pandemic, demand for sophisticated cell harvesting machines increased substantially with the rapid vaccine and biologics development. The broad use of cell-based platforms in the production of vaccines and in therapeutics research drove significant investment in related automation and bioprocessing technologies. The pandemic further underscored the need for self-reliance in biopharmaceutical manufacturing, leading many countries to invest in strengthening their local production capacities. Companies made major investments in modular, automated harvest solutions to ensure they could maintain production under constrained conditions. The market in the post-pandemic era is expected to continue to be supported by growing research funding and partnerships, particularly relating to infectious disease control, regenerative medicine, and biologics development, enabling the market to continue stable growth and technological development.

LATEST TRENDS

Integration of Automation and Single-Use Technologies in Cell Harvesting to Drive Market Growth

One of the key trends impacting the cell harvesting market is the adoption of automation and single-use technologies that can increase efficiency, sterility, and scalability in the bioprocessing. Automated cell harvesting systems decrease handling and exposure to potential sources of contamination, and contribute to standardization of cell yield and quality. As biopharmaceutical companies continue to prioritize monoclonal antibodies, cell-based therapies, and vaccines, they are moving towards closed, automated harvesting solutions designed for continuous, high-throughput operation. Single-use technologies such as disposable centrifuge bags and filters have gained wide acceptance as they represent a more cost-effective option for running multi-purpose plants. They allow quick batch-to-batch turnover, with less downtime, and less cleaning validation. In addition, developments in sensor integration and process analytics enable to monitor cell density and viability in-line during harvesting, potentially improving process control and productivity. This mirrors a broader trend toward digitalized biomanufacturing and Industry 4.0 practices and establishes a new benchmark for the agile and compliant processing of cells.

•   
•   
  

  Request a Free sample to learn more about this report

    

CELL HARVESTING MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into manual and automated

• Manual: The share of manual segment is relatively moderate in cell harvesting market, as these are mainly used in research and academic laboratories on a small scale of application. Manual methods, like centrifugation and filtration, are common because they are simple to perform with minimal initial investment cost. They can be used for experiments that involve frequent modifications and can be directly handled by the researchers. But these approaches are labor-intensive, susceptible to variability, and far less amenable to large-scale manufacturing. The segment still has importance for early-stage development and for a low throughput service despite its limitations.

• Automated: The automated segment holds the cell harvesting market growth as it has promising potential of improving yield, reproducibility, and process safety. Automated harvesting devices mitigate contamination chances, facilitate closed processing, and can be connected to upstream and downstream bioprocessing systems. Their adoption is growing in the production of biopharmaceuticals, which demand product uniformity and compliance with cGMP guidelines. Increasing demand for monoclonal antibodies and cell therapy will continue to drive the shift towards automation.

By Application

Based on application, the global market can be categorized into biopharmaceutical and stem cell research

• Biopharmaceutical: The biopharmaceutical segment holds the major share in the  cell harvesting market, owing to the extensive utilization of cell-based systems in the drug manufacturing process. Effective harvesting of cells is necessary for production of biologics, including vaccines, recombinant proteins, and therapeutic antibodies, among others. The increasing investment in biomanufacturing and growing demand for biologics has further propelled this segment for the utilization of automated and scalable harvesting systems.

• Stem Cell Research: The stem cell research segment is observing robust  growth in the cell harvesting market, due to the developments in regenerative medicine and cell therapy. Viable stem cells must be harvested with minimal damage if they are to be used in downstream applications, such as tissue engineering and personalized medicine. Increasing utilization of single use and closed system harvesting to increase process sterility and maintain viability is also compatible with current and future advances in stem cell therapies.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Demand for Biopharmaceuticals and Cell-Based Therapies to Boost the Market

The growing biopharmaceutical industry is one of the key factors responsible for the cell harvesting market growth. The global demand for biologics, such as monoclonal antibodies, recombinant proteins, and vaccines is rising, and so is the demand for an efficient and scalable cell harvesting system. These systems are widely used in biopharmaceutical companies to recover viable cells and to maximize the product yield and purity in downstream processing. In addition, the increasing emphasis on cell-based therapies and regenerative medicine has favourably impacted the adoption of advanced harvesting techniques that accommodate sensitive cell types. Increasing incident of chronic disease such as cancer, auto-immune and genetic disorders is further propelling cell-based therapeutics research and manufacturing which in turn is driving the market. As industry seeks to improve bioprocessing efficiency, automated and closed-system harvesting platforms are increasingly viewed as crucial for ensuring product quality and regulatory compliance across a production scale.

Technological Advancements in Automated Cell Harvesting Systems to Expand the Market

The cell harvesting market is being positively impacted by the growing automation and bioprocessing technologies in the market. The market is observing shift towards automated cell harvesting system from manual, which provide greater productivity with few risks of contamination and less reproducing trending. These systems are interoperable with upstream and downstream processes to provide a continuous operation under Good Manufacturing Practice (GMP) conditions. Developments such as microfluidic harvesting, single-use bioreactors and continuous bioprocessing are revolutionizing the way cells are separated and harvested at scale. Automation decreases operational cost and human intervention while it delivers high throughput, which is important in the commercial production of biologics. In addition, the advancement of smart monitoring and control systems enhances the tracking of data in real-time to maintain the product yield and quality. Surge in next-generation cell therapies and biologics production in pharmaceutical and biotechnology companies is anticipated to further enhance the adoption of such technological advancements.

Restraining Factor

High Costs and Technical Complexity of Cell Harvesting Systems to Potentially Impede Market Growth

Advanced harvesting systems for cells are expensive, and technical complexity required to use these systems is a significant limiting factor for the growth of the market. The need for substantial investment in capital equipment and infrastructure as well as trained personnel to run and maintain automated and large-scale harvesting systems, however, presents significant barriers to accessibility for small-scale laboratories and facilities in developing markets. Moreover, some cell populations of interest, notably stem cells and primary cells, are fragile and must be handled with exacting care while being separated and collected in order to remain viable and functional, complicating matters further. Manual techniques are more affordable, but those techniques are labour intensive, subject to variability, and not amenable to high volume production. Regulatory compliance, especially in GMPs adds stringent process controls, validation and quality monitoring etc which increases the cost of operations. Together, these financial and technological challenges hinder cell harvesting systems penetration in small-scale research centers and developing countries, constraining the market growth despite the increasing demand for cell-based products.

Expansion of Regenerative Medicine and Stem Cell Research To Create Opportunity for the Product in the Market

Opportunity

Fast growth in regenerative medicine and stem cell research is a primarily source of opportunity in the cell harvesting market. The growing incidences of chronic diseases, genetic disorders, and injuries have increased the demand for the novel therapies, which require to use of quality harvested cells. Stem cell-based therapies, tissue-engineered products, and personalized medicine solutions require cost-effective and aseptic harvesting procedures that allow preservation of the viability and functionality of cells, thus driving demand for innovative solutions.

Furthermore, increasing investments by governments, research organizations, and corporates in the field of regenerative medicine is providing a new momentum for the market for automated and single-use cell harvesting systems. The introduction of digital monitoring, AI-driven process control, closed-system harvesting technologies is enabling higher efficiency and reproducibility and large-scale clinical applications. With the advancing landscape of cell therapy, scaling, reliability, and compliant characterization of harvest solutions are becoming increasingly critical, representing an area of significant growth opportunity for the providers of these solutions in the global market.

Maintaining Cell Viability and Process Standardization Could Be a Potential Challenge for Consumers

Challenge

A major challenge for the cell harvesting market is how to maintain the viability of cells and standardize the processes for various applications. Various types of cells, including stem cells, primary cells and genetically engineered cells, possess particular sensitivities when it comes to handling, separation and storage. Incorrect harvesting can cause cell trauma, loss of yield or function, all of which impact downstream applications in bio-pharmaceutical production or regenerative medicine.

In addition, variation in manual procedures, machinery calibration and process control parameters gives rise to varying results, particularly in the transition from small-scale to large-scale operation. Compliance with regulations adds an additional layer of complexity due to the strict validation, documentation and monitoring required by Good Manufacturing Practice (GMP) standards. Meeting these challenges requires sophisticated automated platforms, on-line monitoring methods and a strong training for operators. If not addressed, these issues can impede adoption, decrease process efficiency, and compromise the reliability of cell-based therapeutics and research results.

•   
•   
  Request a Free sample to learn more about this report

    

CELL HARVESTING MARKET REGIONAL INSIGHTS

• North America

The North American cell harvesting market is experiencing strong growth, led primarily by the United States cell harvesting market due to its robust biotechnology and biopharmaceutical sectors. High adoption of automated and single-use systems in research institutions, hospitals, and biomanufacturing facilities has strengthened market demand. The region benefits from substantial government and private funding for regenerative medicine, stem cell research, and advanced biologics production. Furthermore, the presence of leading technology providers and ongoing innovations in automated harvesting platforms enhance process efficiency and scalability. Rising investments in cell-based therapies, personalized medicine, and vaccine development continue to drive the region’s market expansion.

• Europe

Europe holds a significant cell harvesting market share, driven by the increasing focus on regenerative medicine, stem cell research, and biopharmaceutical manufacturing. Countries like Germany, the U.K., and France are investing heavily in advanced bioprocessing infrastructure and GMP-compliant facilities. Regulatory support and funding for clinical research, along with the adoption of automated and single-use harvesting systems, are enabling efficient cell collection and high viability. The demand for biologics and cell-based therapies in oncology and chronic disease treatment is further boosting market growth.

• Asia

Asia-Pacific dominates the cell harvesting market share due to rapid biotechnology growth, expanding healthcare infrastructure, and increasing clinical research activities in countries such as China, Japan, and India. Rising investments in biopharmaceutical manufacturing, stem cell therapy, and regenerative medicine are driving adoption of automated harvesting systems. Additionally, lower production costs, supportive government initiatives, and the growing presence of international biotech companies are strengthening the region’s market position. The focus on research, cell therapy development, and scalable bioprocessing solutions is expected to sustain strong market growth in the coming years.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Leading players in the cell harvesting market are focusing on innovation, automation, and strategic collaborations to strengthen their global presence and address growing demand for high-quality, scalable cell processing solutions. Companies are investing heavily in the development of automated and single-use harvesting systems that ensure sterility, reproducibility, and high cell viability, catering to biopharmaceutical production and regenerative medicine applications. Several firms are integrating real-time monitoring, AI-driven analytics, and closed-system technologies to enhance process efficiency and compliance with Good Manufacturing Practice (GMP) standards. Strategic partnerships with hospitals, research institutions, and contract development and manufacturing organizations (CDMOs) are expanding market reach and facilitating the adoption of advanced cell harvesting solutions. Additionally, players are emphasizing sustainability by minimizing chemical usage, reducing contamination risk, and optimizing energy efficiency in their systems. These combined efforts position key manufacturers to capture growth opportunities in stem cell research, biopharmaceutical production, and emerging cell therapy markets.

List Of Top Cell Harvesting Companies

• PerkinElmer (United States)
• Brandel (United States)
• Tomtec (Germany)
• Pall Corporation (United States)
• Connectorate (Japan)
• Scinomix (Germany)
• ADSTEC (Japan)
• Sartorius (Germany)
• Inotech Biosystems International (Switzerland)
• Beckman Coulter (Danaher Corporation) (United States)

KEY INDUSTRY DEVELOPMENT

February 2024: Sartorius (Germany) launched its next-generation automated cell harvesting system designed for large-scale biopharmaceutical and stem cell applications. The platform integrates single-use technology with real-time process monitoring and AI-driven analytics to ensure high cell viability, reproducibility, and compliance with Good Manufacturing Practice (GMP) standards. This development addresses the growing demand for scalable and efficient harvesting solutions in regenerative medicine, monoclonal antibody production, and vaccine manufacturing. By reducing manual intervention and contamination risk, the system enhances productivity and process consistency, supporting both research and commercial-scale bioprocessing. The launch represents Sartorius’s strategic focus on innovation and automation, reinforcing its position as a leading provider of advanced cell processing technologies.

REPORT COVERAGE

The report on the cell harvesting market provides a comprehensive analysis of market dynamics, including key drivers, restraints, opportunities, and challenges shaping global growth. It examines segmentation by type—manual and automated—and by application, including biopharmaceutical production and stem cell research, highlighting adoption trends, technological innovations, and efficiency improvements. The study emphasizes the role of automation, single-use technologies, and AI-driven process monitoring in enhancing cell viability, reproducibility, and regulatory compliance.

Regional analysis covers North America, Europe, and Asia-Pacific, detailing market size, growth potential, and investment trends in biotechnology, regenerative medicine, and pharmaceutical manufacturing. The report also profiles leading industry players, examining their strategic initiatives, product innovations, partnerships, and sustainability efforts aimed at expanding global reach. Additionally, it includes recent industrial developments, technological advancements, and forecasted market trends, providing stakeholders with actionable insights to make informed decisions in the evolving landscape of cell harvesting for research, therapeutic, and commercial bioprocessing applications.